Home ➤ Life Science ➤ Diagnostics ➤ Nucleic Acid Amplification Testing Market
Nucleic Acid Amplification Testing Market
Published date: Nov 2025 • Formats:
Request Sample Schedule a Call

Global Nucleic Acid Amplification Testing Market Analysis By Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Ligase Chain Reaction (LCR)), By Product (Instruments and systems, Consumables & kits), By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Blood Screening & Transplant Testing, Research and Forensic Applications, Others), By End-User (Hospitals, Central & Reference Laboratories, Academic & Research Institutes, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Nov 2025
  • Report ID: 164574
  • Number of Pages: 363
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Nucleic Acid Amplification Testing Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Nucleic Acid Amplification Testing Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Nucleic Acid Amplification Testing Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 3.3. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
        • 3.3.1. Polymerase Chain Reaction (PCR)
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
          • 3.3.2.3. Nicking endonuclease amplification reaction (NEAR)
          • 3.3.2.4. Transcription mediated amplification (TMA)
          • 3.3.2.5. Loop-mediated isothermal amplification (LAMP)
          • 3.3.2.6. Helicase-dependent amplification (HDA)
          • 3.3.2.7. Clustered regularly interspaced short palindromic repeats (CRISPR)
          • 3.3.2.8. Strand displacement amplification (SDA)
          • 3.3.2.9. Others
        • 3.3.3. Ligase Chain Reaction (LCR)
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
      • 3.4. Global Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 3.5. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
        • 3.5.1. Instruments and systems
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Consumables & kits
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
      • 3.6. Global Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.7. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
        • 3.7.1. Infectious disease testing
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
          • 3.7.1.3. Tuberculosis testing
          • 3.7.1.4. Influenza testing
          • 3.7.1.5. COVID-19 testing
          • 3.7.1.6. Hepatitis testing
          • 3.7.1.7. Sexually transmitted infections testing
          • 3.7.1.8. Mosquito borne disease testing
          • 3.7.1.9. Others
        • 3.7.2. Oncology testing
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
      • 3.7.3. Genetic & mitochondrial disease testing
        • 3.7.3.1. Insights
        • 3.7.3.2. Key Takeaways
      • 3.7.4. Blood Screening & Transplant Testing
        • 3.7.4.1. Insights
        • 3.7.4.2. Key Takeaways
      • 3.7.5. Research and Forensic Applications
        • 3.7.5.1. Insights
        • 3.7.5.2. Key Takeaways
      • 3.7.6. Others
        • 3.7.6.1. Insights
        • 3.7.6.2. Key Takeaways
      • 3.8. Global Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 3.9. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
        • 3.9.1. Hospitals
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Central & Reference Laboratories
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Academic & Research Institutes
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
        • 3.9.4. Others
          • 3.9.4.1. Insights
          • 3.9.4.2. Key Takeaways
    • 4. Global Nucleic Acid Amplification Testing Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Region
    • 5. North America Nucleic Acid Amplification Testing Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 5.3. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • 5.4. North America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 5.5. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • 5.6. North America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.7. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • 5.8. North America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 5.9. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • 5.10. North America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.11. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Nucleic Acid Amplification Testing Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 6.3. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • 6.4. Europe Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 6.5. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • 6.6. Europe Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.7. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • 6.8. Europe Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 6.9. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • 6.10. Europe Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.11. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherland
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Nucleic Acid Amplification Testing Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 7.3. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • 7.4. Asia Pacific Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 7.5. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • 7.6. Asia Pacific Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.7. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • 7.8. Asia Pacific Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 7.9. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • 7.10. Asia Pacific Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.11. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. Australia
        • 7.11.6. New Zealand
        • 7.11.7. Singapore
        • 7.11.8. Thailand
        • 7.11.9. Vietnam
        • 7.11.10. Rest of Asia Pacific
    • 8. Latin America Nucleic Acid Amplification Testing Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 8.3. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • 8.4. Latin America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 8.5. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • 8.6. Latin America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.7. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • 8.8. Latin America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 8.9. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • 8.10. Latin America Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.11. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Nucleic Acid Amplification Testing Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 9.3. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • 9.4. Middle East & Africa Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 9.5. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • 9.6. Middle East & Africa Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.7. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • 9.8. Middle East & Africa Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 9.9. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • 9.10. Middle East & Africa Nucleic Acid Amplification Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.11. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. F. Hoffmann‑La Roche Ltd.
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Abbott Laboratories
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Becton, Dickinson and Company
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Danaher Corporation
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. bioMérieux SA
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Thermo Fisher Scientific Inc.
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. QIAGEN N.V.
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Siemens Healthineers
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Bio‑Rad Laboratories, Inc.
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Seegene Inc.
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. Hologic, Inc.
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
        • 10.7.12. Agilent Technologies, Inc.
          • 10.7.12.1. Company Details
          • 10.7.12.2. Business Overview
          • 10.7.12.3. Product Portfolio
          • 10.7.12.4. Financial Insights
          • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.12.6. SWOT Analysis
          • 10.7.12.7. Geographic Footprint
        • 10.7.13. Molbio Diagnostics Limited
          • 10.7.13.1. Company Details
          • 10.7.13.2. Business Overview
          • 10.7.13.3. Product Portfolio
          • 10.7.13.4. Financial Insights
          • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.13.6. SWOT Analysis
          • 10.7.13.7. Geographic Footprint
        • 10.7.14. Illumina, Inc.
          • 10.7.14.1. Company Details
          • 10.7.14.2. Business Overview
          • 10.7.14.3. Product Portfolio
          • 10.7.14.4. Financial Insights
          • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.14.6. SWOT Analysis
          • 10.7.14.7. Geographic Footprint
        • 10.7.15. Mylab Discovery Solutions
          • 10.7.15.1. Company Details
          • 10.7.15.2. Business Overview
          • 10.7.15.3. Product Portfolio
          • 10.7.15.4. Financial Insights
          • 10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.15.6. SWOT Analysis
          • 10.7.15.7. Geographic Footprint
        • 10.7.16. Randox Laboratories Ltd.
          • 10.7.16.1. Company Details
          • 10.7.16.2. Business Overview
          • 10.7.16.3. Product Portfolio
          • 10.7.16.4. Financial Insights
          • 10.7.16.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.16.6. SWOT Analysis
          • 10.7.16.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 2. Global Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 3. Global Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 4. Global Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 5. Global Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 6. Global Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 7. Global Nucleic Acid Amplification Testing Market Value (US$ Mn), By Region, 2020-2034
      • Table 8. North America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 9. North America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 10. North America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 11. North America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 12. North America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 13. North America Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 14. North America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 15. The US Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 16. The US Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 17. The US Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 18. The US Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 19. The US Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 20. The US Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 21. Canada Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 22. Canada Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 23. Canada Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 24. Canada Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 25. Canada Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 26. Canada Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 27. Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 28. Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 29. Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 30. Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 31. Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 32. Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 33. Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 34. Germany Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 35. Germany Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 36. Germany Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 37. Germany Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 38. Germany Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 39. Germany Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 40. The UK Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 41. The UK Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 42. The UK Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 43. The UK Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 44. The UK Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 45. The UK Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 46. France Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 47. France Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 48. France Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 49. France Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 50. France Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 51. France Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 52. Spain Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 53. Spain Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 54. Spain Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 55. Spain Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 56. Spain Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 57. Spain Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 58. Italy Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 59. Italy Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 60. Italy Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 61. Italy Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 62. Italy Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 63. Italy Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 64. Russia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 65. Russia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 66. Russia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 67. Russia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 68. Russia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 69. Russia Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 70. Netherland Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 71. Netherland Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 72. Netherland Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 73. Netherland Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 74. Netherland Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 75. Netherland Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 76. Rest of Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 77. Rest of Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 78. Rest of Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 79. Rest of Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 80. Rest of Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 81. Rest of Europe Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 82. Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 83. Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 84. Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 85. Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 86. Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 87. Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 88. Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 89. China Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 90. China Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 91. China Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 92. China Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 93. China Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 94. China Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 95. India Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 96. India Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 97. India Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 98. India Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 99. India Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 100. India Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 101. Japan Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 102. Japan Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 103. Japan Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 104. Japan Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 105. Japan Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 106. Japan Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 107. South Korea Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 108. South Korea Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 109. South Korea Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 110. South Korea Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 111. South Korea Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 112. South Korea Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 113. Australia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 114. Australia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 115. Australia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 116. Australia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 117. Australia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 118. Australia Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 119. New Zealand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 120. New Zealand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 121. New Zealand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 122. New Zealand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 123. New Zealand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 124. New Zealand Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 125. Singapore Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 126. Singapore Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 127. Singapore Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 128. Singapore Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 129. Singapore Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 130. Singapore Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 131. Thailand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 132. Thailand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 133. Thailand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 134. Thailand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 135. Thailand Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 136. Thailand Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 137. Vietnam Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 138. Vietnam Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 139. Vietnam Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 140. Vietnam Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 141. Vietnam Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 142. Vietnam Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 143. Rest of Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 144. Rest of Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 145. Rest of Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 146. Rest of Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 147. Rest of Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 148. Rest of Asia Pacific Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 149. Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 150. Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 151. Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 152. Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 153. Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 154. Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 155. Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 156. Brazil Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 157. Brazil Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 158. Brazil Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 159. Brazil Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 160. Brazil Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 161. Brazil Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 162. Mexico Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 163. Mexico Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 164. Mexico Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 165. Mexico Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 166. Mexico Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 167. Mexico Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 168. Rest of Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 169. Rest of Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 170. Rest of Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 171. Rest of Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 172. Rest of Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 173. Rest of Latin America Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 174. Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 175. Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 176. Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 177. Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 178. Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 179. Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 180. Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 181. South Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 182. South Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 183. South Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 184. South Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 185. South Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 186. South Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 187. Saudi Arabia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 188. Saudi Arabia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 189. Saudi Arabia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 190. Saudi Arabia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 191. Saudi Arabia Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 192. Saudi Arabia Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 193. UAE Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 194. UAE Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 195. UAE Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 196. UAE Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 197. UAE Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 198. UAE Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
      • Table 199. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 200. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Table 201. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Product, 2020-2034
      • Table 202. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Application, 2020-2034
      • Table 203. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By Infectious disease testing, 2020-2034
      • Table 204. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market Value (US$ Mn), By End-User, 2020-2034
    • List of Figures
      • Figure 1. Global Nucleic Acid Amplification Testing Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Nucleic Acid Amplification Testing Market
      • Figure 5. Global Nucleic Acid Amplification Testing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 6. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • Figure 7. Global Nucleic Acid Amplification Testing Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 8. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • Figure 9. Global Nucleic Acid Amplification Testing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 10. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • Figure 11. Global Nucleic Acid Amplification Testing Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 12. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • Figure 13. Global Nucleic Acid Amplification Testing Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 14. Global Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Region
      • Figure 15. North America Nucleic Acid Amplification Testing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 16. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • Figure 17. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 18. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Isothermal Nucleic Acid Amplification Product (INAAT), 2020-2034
      • Figure 19. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Ligase Chain Reaction (LCR), 2020-2034
      • Figure 20. North America Nucleic Acid Amplification Testing Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 21. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • Figure 22. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Instruments and systems, 2020-2034
      • Figure 23. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Consumables & kits, 2020-2034
      • Figure 24. North America Nucleic Acid Amplification Testing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 25. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • Figure 26. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Infectious disease testing, 2020-2034
      • Figure 27. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Oncology testing, 2020-2034
      • Figure 28. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Genetic & mitochondrial disease testing, 2020-2034
      • Figure 29. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Blood Screening & Transplant Testing, 2020-2034
      • Figure 30. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Research and Forensic Applications, 2020-2034
      • Figure 31. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 32. North America Nucleic Acid Amplification Testing Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 33. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • Figure 34. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 35. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Central & Reference Laboratories, 2020-2034
      • Figure 36. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 37. North America Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 38. North America Nucleic Acid Amplification Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 39. North America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
      • Figure 40. Europe Nucleic Acid Amplification Testing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 41. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • Figure 42. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 43. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 44. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Ligase Chain Reaction (LCR), 2020-2034
      • Figure 45. Europe Nucleic Acid Amplification Testing Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 46. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • Figure 47. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Instruments and systems, 2020-2034
      • Figure 48. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Consumables & kits, 2020-2034
      • Figure 49. Europe Nucleic Acid Amplification Testing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 50. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • Figure 51. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Infectious disease testing, 2020-2034
      • Figure 52. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Oncology testing, 2020-2034
      • Figure 53. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Genetic & mitochondrial disease testing, 2020-2034
      • Figure 54. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Blood Screening & Transplant Testing, 2020-2034
      • Figure 55. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Research and Forensic Applications, 2020-2034
      • Figure 56. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 57. Europe Nucleic Acid Amplification Testing Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 58. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • Figure 59. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 60. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Central & Reference Laboratories, 2020-2034
      • Figure 61. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 62. Europe Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 63. Europe Nucleic Acid Amplification Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 64. Europe Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
      • Figure 65. Asia Pacific Nucleic Acid Amplification Testing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 66. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • Figure 67. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 68. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 69. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Ligase Chain Reaction (LCR), 2020-2034
      • Figure 70. Asia Pacific Nucleic Acid Amplification Testing Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 71. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • Figure 72. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Instruments and systems, 2020-2034
      • Figure 73. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Consumables & kits, 2020-2034
      • Figure 74. Asia Pacific Nucleic Acid Amplification Testing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 75. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • Figure 76. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Infectious disease testing, 2020-2034
      • Figure 77. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Oncology testing, 2020-2034
      • Figure 78. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Genetic & mitochondrial disease testing, 2020-2034
      • Figure 79. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Blood Screening & Transplant Testing, 2020-2034
      • Figure 80. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Research and Forensic Applications, 2020-2034
      • Figure 81. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 82. Asia Pacific Nucleic Acid Amplification Testing Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 83. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • Figure 84. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 85. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Central & Reference Laboratories, 2020-2034
      • Figure 86. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 87. Asia Pacific Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 88. Asia Pacific Nucleic Acid Amplification Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 89. Asia Pacific Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
      • Figure 90. Latin America Nucleic Acid Amplification Testing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 91. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • Figure 92. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 93. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 94. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Ligase Chain Reaction (LCR), 2020-2034
      • Figure 95. Latin America Nucleic Acid Amplification Testing Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 96. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • Figure 97. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Instruments and systems, 2020-2034
      • Figure 98. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Consumables & kits, 2020-2034
      • Figure 99. Latin America Nucleic Acid Amplification Testing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 100. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • Figure 101. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Infectious disease testing, 2020-2034
      • Figure 102. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Oncology testing, 2020-2034
      • Figure 103. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Genetic & mitochondrial disease testing, 2020-2034
      • Figure 104. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Blood Screening & Transplant Testing, 2020-2034
      • Figure 105. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Research and Forensic Applications, 2020-2034
      • Figure 106. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 107. Latin America Nucleic Acid Amplification Testing Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 108. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • Figure 109. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 110. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Central & Reference Laboratories, 2020-2034
      • Figure 111. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 112. Latin America Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 113. Latin America Nucleic Acid Amplification Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 114. Latin America Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country
      • Figure 115. Middle East & Africa Nucleic Acid Amplification Testing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 116. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Technology
      • Figure 117. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 118. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 119. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Ligase Chain Reaction (LCR), 2020-2034
      • Figure 120. Middle East & Africa Nucleic Acid Amplification Testing Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 121. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Product
      • Figure 122. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Instruments and systems, 2020-2034
      • Figure 123. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Consumables & kits, 2020-2034
      • Figure 124. Middle East & Africa Nucleic Acid Amplification Testing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 125. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Application
      • Figure 126. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Infectious disease testing, 2020-2034
      • Figure 127. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Oncology testing, 2020-2034
      • Figure 128. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Genetic & mitochondrial disease testing, 2020-2034
      • Figure 129. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Blood Screening & Transplant Testing, 2020-2034
      • Figure 130. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Research and Forensic Applications, 2020-2034
      • Figure 131. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 132. Middle East & Africa Nucleic Acid Amplification Testing Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 133. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By End-User
      • Figure 134. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 135. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Central & Reference Laboratories, 2020-2034
      • Figure 136. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 137. Middle East & Africa Nucleic Acid Amplification Testing Market (US$ Mn), by Others, 2020-2034
      • Figure 138. Middle East & Africa Nucleic Acid Amplification Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 139. Middle East & Africa Nucleic Acid Amplification Testing Market Attractiveness Analysis, By Country

Related Reports

Our Clients

  • Our Clients
Nucleic Acid Amplification Testing Market
  • 164574
  • Nov 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options